Fabry Disease Global Clinical Trials Review, H1, 2013

Date: February 15, 2013
Pages: 85
Price:
US$ 2,500.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: F39CE938D4EEN
Leaflet:

Download PDF Leaflet

Fabry Disease Global Clinical Trials Review, H1, 2013

SUMMARY

GlobalData's clinical trial report, ' Fabry Disease Global Clinical Trials Review, H1, 2013" provides data on the Fabry Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fabry Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Fabry Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
REASONS TO BUY
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Introduction
Fabry Disease
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Fabry Disease
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Fabry Disease Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Genzyme Corporation
Clinical Trial Overview of Genzyme Corporation
Amicus Therapeutics, Inc.
Clinical Trial Overview of Amicus Therapeutics, Inc.
Shire Plc
Clinical Trial Overview of Shire Plc
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Sanofi
Clinical Trial Overview of Sanofi
Green Cross Corporation
Clinical Trial Overview of Green Cross Corporation
Shire Human Genetic Therapies, Inc.
Clinical Trial Overview of Shire Human Genetic Therapies, Inc.
Protalix Ltd.
Clinical Trial Overview of Protalix Ltd.
Genzyme BV
Clinical Trial Overview of Genzyme BV
O & O Alpan, LLC
Clinical Trial Overview of O & O Alpan, LLC
GlaxoSmithKline Inc.
Clinical Trial Overview of GlaxoSmithKline Inc.
ISU ABXIS Co.,Ltd.
Clinical Trial Overview of ISU ABXIS Co.,Ltd.
GlaxoSmithKline AG
Clinical Trial Overview of GlaxoSmithKline AG
Abbott Laboratories
Clinical Trial Overview of Abbott Laboratories
Clinical Trial Overview of Top Universities / Institutes / Hospitals
University of Alabama at Birmingham
Clinical Trial Overview of University of Alabama at Birmingham
Baylor Research Institute
Clinical Trial Overview of Baylor Research Institute
University of Rostock
Clinical Trial Overview of University of Rostock
University of Minnesota
Clinical Trial Overview of University of Minnesota
Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Clinical Trial Overview of Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
Canadian Fabry Research Consortium
Clinical Trial Overview of Canadian Fabry Research Consortium
Assistance Publique - Hopitaux de Paris
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
Wolfson Medical Center
Clinical Trial Overview of Wolfson Medical Center
Academic Medical Centre
Clinical Trial Overview of Academic Medical Centre
Mario Negri Institute for Pharmacological Research
Clinical Trial Overview of Mario Negri Institute for Pharmacological Research
Danish Pain Research Center
Clinical Trial Overview of Danish Pain Research Center
Ghent University Hospital
Clinical Trial Overview of Ghent University Hospital
University of Zurich
Clinical Trial Overview of University of Zurich
Shaare Zedek Medical Center
Clinical Trial Overview of Shaare Zedek Medical Center
University Hospital, Bordeaux
Clinical Trial Overview of University Hospital, Bordeaux
Medical University of Vienna
Clinical Trial Overview of Medical University of Vienna
The Ohio State University
Clinical Trial Overview of The Ohio State University
Cedars-Sinai Medical Center
Clinical Trial Overview of Cedars-Sinai Medical Center
Centre Hospitalier Universitaire de Nice
Clinical Trial Overview of Centre Hospitalier Universitaire de Nice
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Fabry Disease Therapeutics Market, Global, Clinical Trials by Zone, 2013*
Fabry Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2013*
Fabry Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013*
Fabry Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013*
Fabry Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2013*
Fabry Disease Therapeutics Clinical Trials, North America, Top Countries, 2013*
Fabry Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013*
Fabry Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013*
Fabry Disease Therapeutics Clinical Trials, BRIC Countries, 2013*
Fabry Disease Therapeutics Clinical Trials, G7 Countries, 2013*
Fabry Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013*
Fabry Disease Therapeutics Clinical Trials, E7 Countries, 2013*
Fabry Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013*
Fabry Disease Therapeutics Market, Global, Clinical Trials by Phase, 2013*
Fabry Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013*
Fabry Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2013*
Fabry Disease Therapeutics Market, Global, Withdrawn Clinical Trials, 2013*
Fabry Disease Therapeutics Market, Global, Terminated Clinical Trials, 2013*
Fabry Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012
Fabry Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2013*
Fabry Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013*
Fabry Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme Corporation, 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Amicus Therapeutics, Inc., 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Green Cross Corporation, 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Human Genetic Therapies, Inc., 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Protalix Ltd., 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme BV, 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by O & O Alpan, LLC, 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Inc., 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by ISU ABXIS Co.,Ltd., 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline AG, 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor Research Institute, 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rostock, 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Canadian Fabry Research Consortium, 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Wolfson Medical Center, 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Centre, 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Mario Negri Institute for Pharmacological Research, 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Danish Pain Research Center, 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Ghent University Hospital, 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Shaare Zedek Medical Center, 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Bordeaux, 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The Ohio State University, 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Cedars-Sinai Medical Center, 2013*
Fabry Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Centre Hospitalier Universitaire de Nice, 2013*

LIST OF FIGURES

Fabry Disease Therapeutics Market, Global, Clinical Trials by Zone (%), 2013*
Fabry Disease Therapeutics Market, Global, Clinical Trials by Top Countries, 2013*
Fabry Disease Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013*
Fabry Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013*
Fabry Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013*
Fabry Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2013*
Fabry Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013*
Fabry Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013*
Fabry Disease Therapeutics Clinical Trials, G7 Countries (%), 2013*
Fabry Disease Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013*
Fabry Disease Therapeutics Clinical Trials, E7 Countries (%), 2013*
Fabry Disease Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013*
Fabry Disease Therapeutics Market, Global, Clinical Trials by Phase (%), 2013*
Fabry Disease Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013*
Fabry Disease Therapeutics Market, Global, Clinical Trials by Trial Status, 2013*
Fabry Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012
Fabry Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2013*
Fabry Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013*
Fabry Disease Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013*
GlobalData Methodology

Ask Your Question

Fabry Disease Global Clinical Trials Review, H1, 2013
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: